NASDAQ : CBUS
Cibus, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.35 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 103.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cibus, Inc. (CBUS) reported revenue of 4.35M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.35M | 3.64M | 4.26M | 1.82M | 157.00K | 25.99M |
| Cost of Revenue | 28.56M | |||||
| Gross Profit | 4.35M | 3.64M | 4.26M | 1.82M | 157.00K | -2.57M |
| Selling, General & Admin | 20.89M | 26.91M | 30.80M | 22.41M | 10.97M | 15.43M |
| Research & Development | 37.39M | 44.20M | 50.43M | 41.07M | 11.55M | 11.34M |
| Operating Expenses | 58.29M | 71.10M | 81.23M | 63.48M | 22.53M | 26.76M |
| Operating Income | -53.94M | -67.46M | -76.96M | -61.66M | -22.37M | -29.33M |
| Interest Expense | -37.03M | -35.48M | -34.19M | -18.89M | -87.00K | -1.43M |
| Interest & Investment Income | 352.00K | 438.00K | 631.00K | 527.00K | 17.00K | |
| Currency Exchange Gain (Loss) | 732.00K | |||||
| Other Non Operating Income (Expenses) | 132.00K | 400.00K | 9.27M | -1.13M | 5.57M | 19.00K |
| EBT Excluding Unusual Items | -90.49M | -102.11M | -101.25M | -80.42M | -16.89M | -30.73M |
| Merger & Restructuring Charges | -7.80M | |||||
| Impairment of Goodwill | -20.95M | -181.43M | -150.37M | |||
| Asset Writedown | -9.12M | -9.12M | -99.05M | |||
| Other Unusual Items | 1.53M | |||||
| Pretax Income | -99.61M | -132.17M | -282.68M | -337.64M | -16.89M | -29.20M |
| Income Tax Expense | 13.00K | 29.00K | 29.00K | -4.00K | ||
| Earnings From Continuing Operations | -99.62M | -132.20M | -282.71M | -337.64M | -16.89M | -29.20M |
| Minority Interest in Earnings | 1.42M | 5.12M | 31.32M | 70.01M | ||
| Net Income | -98.19M | -127.08M | -251.39M | -267.63M | -16.89M | -29.20M |
| Net Income to Common | -98.19M | -127.08M | -251.39M | -267.63M | -16.89M | -29.20M |
| Shares Outstanding (Basic) | 62.09M | 45.76M | 23.22M | 10.31M | 919.96K | 749.51K |
| Shares Outstanding (Diluted) | 62.09M | 45.76M | 23.22M | 10.31M | 919.96K | 749.51K |
| EPS (Basic) | -1.58 | -2.78 | -10.83 | -25.95 | -18.36 | -38.96 |
| EPS (Diluted) | -1.58 | -2.78 | -10.83 | -25.95 | -18.36 | -38.96 |
| Free Cash Flow | -46.32M | -51.17M | -58.85M | -50.53M | -20.88M | -19.31M |
| Free Cash Flow Per Share | -0.75 | -1.12 | -2.53 | -4.90 | -22.70 | -25.76 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | -9.89% |
| Operating Margin | -1,240.90% | -1,853.92% | -1,805.82% | -3,393.73% | -14,248.41% | -112.87% |
| Profit Margin | -2,258.89% | -3,492.31% | -5,898.36% | -14,729.06% | -10,758.60% | -112.36% |
| Free Cash Flow Margin | -1,065.58% | -1,406.13% | -1,380.83% | -2,781.01% | -13,301.91% | -74.30% |
| EBITDA | -48.87M | -61.54M | -70.11M | -56.97M | -20.84M | -26.99M |
| EBITDA Margin | -103.88% | |||||
| D&A For EBITDA | 5.07M | 5.92M | 6.86M | 4.69M | 1.53M | 2.34M |
| EBIT | -53.94M | -67.46M | -76.96M | -61.66M | -22.37M | -29.33M |
| EBIT Margin | -112.87% | |||||
| Revenue as Reported | 4.35M | 3.64M | 4.26M | 1.82M | 157.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 20.43M | 9.92M | 14.43M | 32.70M | 3.43M | 13.82M |
| Cash & Short-Term Investments | 20.43M | 9.92M | 14.43M | 32.70M | 3.43M | 13.82M |
| Accounts Receivable | 1.14M | 703.00K | 1.24M | 730.00K | ||
| Receivables | 1.14M | 703.00K | 1.24M | 730.00K | ||
| Prepaid Expenses | 1.89M | 1.44M | 1.27M | 1.79M | 606.00K | 859.00K |
| Restricted Cash | 99.00K | 499.00K | ||||
| Total Current Assets | 23.46M | 12.07M | 16.95M | 35.22M | 4.13M | 15.18M |
| Property, Plant & Equipment | 25.93M | 27.86M | 44.69M | 37.46M | 18.13M | 21.73M |
| Goodwill | 232.52M | 232.52M | 253.47M | 434.90M | ||
| Other Intangible Assets | 30.77M | 31.68M | 33.58M | 35.41M | 158.00K | |
| Other Long-Term Assets | 771.00K | 926.00K | 1.39M | 1.42M | 282.00K | |
| Total Assets | 313.45M | 305.05M | 350.07M | 544.41M | 22.42M | 37.19M |
| Accounts Payable | 5.61M | 8.07M | 5.96M | 6.13M | 340.00K | 1.26M |
| Accrued Expenses | 4.50M | 5.01M | 5.59M | 5.61M | 280.00K | 2.86M |
| Current Portion of Long-Term Debt | 812.00K | 435.00K | 436.00K | 833.00K | ||
| Current Portion of Leases | 2.86M | 2.73M | 4.40M | 6.11M | 464.00K | 370.00K |
| Current Unearned Revenue | 627.00K | 536.00K | 932.00K | 1.21M | 107.00K | |
| Other Current Liabilities | 38.00K | 79.00K | 2.56M | 1.43M | 471.00K | 363.00K |
| Total Current Liabilities | 14.45M | 16.86M | 19.88M | 21.32M | 1.66M | 4.85M |
| Long-Term Debt | 253.57M | 235.02M | 199.67M | 165.79M | ||
| Long-Term Leases | 29.02M | 29.78M | 31.22M | 17.14M | 13.45M | 17.51M |
| Other Long-Term Liabilities | 1.61M | 1.56M | 1.47M | 1.87M | 79.00K | 702.00K |
| Total Liabilities | 298.64M | 283.22M | 252.24M | 206.12M | 15.19M | 23.06M |
| Common Stock | 13.00K | 11.00K | 9.00K | 8.00K | 5.00K | 4.00K |
| Additional Paid-In Capital | 918.64M | 882.17M | 825.30M | 775.02M | 220.42M | 211.26M |
| Retained Earnings | -901.62M | -858.25M | -731.17M | -479.78M | -212.15M | -196.09M |
| Treasury Stock | -2.26M | -2.14M | -2.00M | -1.78M | -1.04M | -1.04M |
| Comprehensive Income & Other | 24.00K | 39.00K | 15.00K | 8.00K | ||
| Total Common Equity | 14.80M | 21.83M | 92.16M | 293.47M | 7.23M | 14.13M |
| Minority Interest | 5.67M | 44.82M | ||||
| Shareholders' Equity | 14.80M | 21.83M | 97.83M | 338.29M | 7.23M | 14.13M |
| Total Liabilities & Equity | 313.45M | 305.05M | 350.07M | 544.41M | 22.42M | 37.19M |
| Total Debt | 286.26M | 267.96M | 235.73M | 189.87M | 13.91M | 17.88M |
| Net Cash (Debt) | -265.83M | -258.04M | -221.29M | -157.17M | -10.48M | -4.05M |
| Net Cash Per Share | -4.28 | -5.64 | -9.53 | -15.24 | -11.40 | -5.41 |
| Filing Date Shares Outstanding | 76.43M | 69.20M | 32.64M | 20.99M | 987.52K | 854.38K |
| Total Common Shares Outstanding | 76.42M | 54.33M | 27.94M | 19.93M | 976.89K | 775.48K |
| Working Capital | 9.01M | -4.79M | -2.93M | 13.90M | 2.47M | 10.33M |
| Book Value Per Share | 0.19 | 0.40 | 3.30 | 14.73 | 7.40 | 18.22 |
| Tangible Book Value | -248.48M | -242.37M | -194.89M | -176.84M | 7.08M | 14.13M |
| Tangible Book Value Per Share | -3.25 | -4.46 | -6.98 | -8.87 | 7.24 | 18.22 |
| Buildings | 900.00K | 900.00K | 900.00K | 900.00K | 900.00K | 804.00K |
| Machinery | 19.98M | 19.83M | 19.58M | 18.86M | 8.71M | 6.28M |
| Construction In Progress | 155.00K | 216.00K | 704.00K | 849.00K | ||
| Leasehold Improvements | 2.46M | 2.46M | 4.26M | 3.91M | 364.00K | 10.24M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -98.19M | -127.08M | -251.39M | -267.63M | -16.89M | -29.20M |
| Depreciation & Amortization | 5.07M | 5.92M | 6.86M | 4.69M | 1.53M | 2.34M |
| Loss (Gain) From Sale of Assets | -35.00K | 41.00K | 335.00K | 224.00K | ||
| Asset Writedown & Restructuring Costs | 9.12M | 30.07M | 181.43M | 249.42M | ||
| Stock-Based Compensation | 6.77M | 8.19M | 10.75M | 16.09M | 4.00M | 2.09M |
| Other Operating Activities | 35.56M | 29.96M | -6.41M | -49.97M | -5.12M | -1.53M |
| Change in Accounts Receivable | 115.00K | 538.00K | -512.00K | 1.70M | 4.89M | |
| Change in Inventory | 1.38M | |||||
| Change in Accounts Payable | -269.00K | 720.00K | -188.00K | 2.00K | -229.00K | -360.00K |
| Change in Unearned Revenue | -298.00K | -403.00K | -285.00K | -89.00K | -56.00K | |
| Change in Other Net Operating Assets | -3.89M | 1.47M | 1.37M | -656.00K | -2.60M | 1.58M |
| Operating Cash Flow | -46.05M | -50.59M | -58.04M | -46.21M | -19.36M | -18.81M |
| Capital Expenditures | -267.00K | -578.00K | -808.00K | -4.32M | -1.52M | -497.00K |
| Cash Acquisitions | 59.38M | |||||
| Investment in Securities | 11.70M | |||||
| Investing Cash Flow | -224.00K | -578.00K | -808.00K | 55.06M | -1.52M | 11.20M |
| Long-Term Debt Issued | 204.00K | 3.88M | ||||
| Total Debt Issued | 204.00K | 3.88M | ||||
| Long-Term Debt Repaid | -1.11M | -1.08M | -1.57M | -376.00K | -364.00K | |
| Total Debt Repaid | -1.18M | -1.11M | -1.08M | -1.57M | -376.00K | -364.00K |
| Net Debt Issued (Repaid) | -1.18M | -1.11M | -879.00K | 2.31M | -376.00K | -364.00K |
| Issuance of Common Stock | 37.26M | 50.10M | 43.90M | 20.31M | 11.54M | 4.61M |
| Repurchase of Common Stock | -218.00K | -142.00K | -214.00K | -742.00K | ||
| Other Financing Activities | -5.61M | -2.20M | -2.21M | -1.55M | -1.17M | -501.00K |
| Financing Cash Flow | 30.25M | 46.65M | 40.60M | 20.32M | 9.99M | 3.74M |
| Foreign Exchange Rate Adjustments | -9.00K | 11.00K | -13.00K | 3.00K | ||
| Net Cash Flow | -16.03M | -4.51M | -18.27M | 29.17M | -10.89M | -3.87M |
| Free Cash Flow | -46.32M | -51.17M | -58.85M | -50.53M | -20.88M | -19.31M |
| Free Cash Flow Margin | -1,065.58% | -1,406.13% | -1,380.83% | -2,781.01% | -13,301.91% | -74.30% |
| Free Cash Flow Per Share | -0.75 | -1.12 | -2.53 | -4.90 | -22.70 | -25.76 |
| Levered Free Cash Flow | -52.46M | -51.79M | -52.00M | -22.52M | -12.66M | -8.16M |
| Unlevered Free Cash Flow | -29.32M | -29.61M | -30.63M | -10.71M | -12.60M | -7.26M |
| Cash Interest Paid | 49.00K | 79.00K | 115.00K | 123.00K | 69.00K | 1.43M |
| Change in Working Capital | -4.34M | 2.32M | 383.00K | 961.00K | -2.88M | 7.49M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 96.30M | 91.71M | 73.55M | 372.10M | 7.20M | 82.02M |
| Enterprise Value | 362.13M | 328.92M | 285.43M | 652.85M | 13.84M | 86.06M |
| Last Close Price | 1.29 | 1.74 | 2.78 | 19.64 | 7.38 | 106.50 |
| PS Ratio | 22.94 | 25.20 | 17.26 | 204.79 | 45.89 | 3.16 |
| PB Ratio | 6.66 | 4.20 | 0.75 | 1.10 | 1.00 | 5.80 |
| P/TBV Ratio | 1.02 | 5.80 | ||||
| EV/Sales Ratio | 84.10 | 90.39 | 66.97 | 359.30 | 88.17 | 3.31 |
| Debt / Equity Ratio | 19.34 | 12.28 | 2.41 | 0.56 | 1.92 | 1.26 |
| Net Debt / Equity Ratio | 17.96 | 11.82 | 2.26 | 0.47 | 1.45 | 0.29 |
| Net Debt / EBITDA Ratio | -5.44 | -4.19 | -3.16 | -2.76 | -0.50 | -0.15 |
| Net Debt / FCF Ratio | -5.74 | -5.04 | -3.76 | -3.11 | -0.50 | -0.21 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.52 |
| Quick Ratio | 1.49 | 0.63 | 0.79 | 1.57 | 2.06 | 2.85 |
| Current Ratio | 1.62 | 0.72 | 0.85 | 1.65 | 2.49 | 3.13 |
| Return on Equity (ROE) | -223.16% | -220.96% | -129.65% | -195.43% | -158.12% | -114.49% |
| Return on Assets (ROA) | -10.22% | -12.87% | -10.76% | -13.60% | -46.91% | -36.48% |
| Return on Capital Employed (ROCE) | -18.00% | -23.40% | -23.30% | -11.80% | -107.80% | -90.70% |
| Earnings Yield | -125.52% | -138.57% | -341.81% | -71.92% | -234.46% | -35.60% |
| FCF Yield | -46.44% | -55.79% | -80.02% | -13.58% | -289.89% | -23.54% |
| Buyback Yield / Dilution | -95.73% | -97.04% | -125.14% | -1,021.20% | -22.74% | -10.61% |